颈动脉体瘤患者合并粥样斑块的风险评估

杨 凌1, 武 建英2
1、青海大学研究生院
2、青海大学附属医院心脏血管外科

摘要


颈动脉体瘤（CBT）是一种罕见的头颈部高血管瘤，其发病机制尚不明确，慢性缺氧是公认的主要致病因
素。CBT的治疗方式主要包括手术切除、药物治疗和介入治疗，缺血性脑卒中是最严重的术后并发症之一。而颈动
脉斑块的形成与其密切相关，其成因涉及多种风险因素。当前常用的检出方法包括超声检查、CT扫描、MRI、DSA等。
每种技术各有优劣，适用于不同的临床场景。DRGs作为一种国际标准的医疗分类和支付系统，旨在提高医疗服务透
明度、效率和公平性，减轻患者的经济负担。通过结合影像学检查和风险评估模型，可以更精准地筛选CBT合并斑
块的高危患者，优化术前诊疗策略，有助于患者生活质量的提高和DRGs的推广。故本文对导致CBT合并粥样斑块
的风险评估进行综述。

关键词


颈动脉体瘤；动脉粥样硬化斑块；超声；计算机断层扫描；磁共振；DRGs

全文:

PDF


参考


[1]Grufferman S, Gillman MW, Pasternak LR, Peterson

CL, Young WG Jr. Familial carotid body tumors: case report

and epidemiologic review. Cancer. 1980 Nov 1;46(9):2116-

22. doi: 10.1002/1097-0142(19801101)46:9<2116::aidcncr2820460934>3.0.co;2-s. PMID: 7000334.

[2]Zbaren P, Lehmann W. Carotid body paraganglioma

with metastases. Laryngoscope. 1985 Apr;95(4):450-4. doi:

10.1288/00005537-198504000-00014. PMID: 3982185.

[3]Netterville JL, Reilly KM, Robertson D, Reiber

ME, Armstrong WB, Childs P. Carotid body tumors: a

review of 30 patients with 46 tumors. Laryngoscope. 1995

Feb;105(2):115-26. doi: 10.1288/00005537-199502000-

00002. PMID: 8544589.

[4]佘志强，刘继远，颈动脉体瘤的诊治进展[J].国

际耳鼻咽喉头颈外科杂志，2016，40（3）：168-172.

[5]Sanghvi VD, Chandawarkar RY. Carotid body

tumors. J Surg Oncol. 1993 Nov;54(3):190-2. doi: 10.1002/

jso.2930540314. PMID: 8412178.

[6]Shamblin WR, ReMine WH, Sheps SG, Harrison EG

Jr. Carotid body tumor (chemodectoma). Clinicopathologic

analysis of ninety cases. Am J Surg. 1971 Dec;122(6):732-9.

doi: 10.1016/0002-9610(71)90436-3. PMID: 5127724.

[7]Chandel NS,Maltepe E,Maieu CE et al.Mitochondrial

reactive oxygen species trigge rhypoxia induced

transcription[J].Prec Natl Sci USA,1998,95(20):11715-11720.

[8]Astrom K,Cohen JE,Willett Brozick JE et al.Altitude

is a phenotypic modifier in here ditary paraganglioma

type 1:evidence for an oxygen-sensing defect[J].Hum

Genet,2003,113(3):228-237.

[9]Astuti D, Hart-Holden N, Latif F, Lalloo F, Black

GC, Lim C, Moran A, Grossman AB, Hodgson SV, Freemont

A, Ramsden R, Eng C, Evans DG, Maher ER. Genetic

analysis of mitochondrial complex II subunits SDHD, SDHB

and SDHC in paraganglioma and phaeochromocytoma

susceptibility. Clin Endocrinol (Oxf). 2003 Dec;59(6):728-33.

doi: 10.1046/j.1365-2265.2003.01914.x. PMID: 14974914.

[10]Ward PH, Jenkins HA, Hanafee WN. Diagnosis

and treatment of carotid body tumors. Ann Otol Rhinol

Laryngol. 1978 Sep-Oct;87(5 Pt 1):614-21. doi:

10.1177/000348947808700503. PMID: 718058.

[11]Jiang X, Fang G, Guo D, Xu X, Chen B, Jiang J,

Dong Z, Fu W. Surgical Management of Carotid Body Tumor

and Risk Factors of Postoperative Cranial Nerve Injury. World J

Surg. 2020 Dec;44(12):4254-4260. doi: 10.1007/s00268-020-

05723-8. Epub 2020 Aug 17. PMID: 32804251.

[12]陈 婷， 沈 暘， 朱 江.颈 动 脉 体 瘤 的 外 科 治 疗

及并发症预防与处理[J].临床耳鼻咽喉头颈外科杂志，2018，32（09）：713-716.DOI：10.13201/j.issn.1001-

1781.2018.09.018.

[13]孙欣栋，鲍海华.磁共振高分辨率血管壁成像对

颈动脉体瘤合并颈动脉斑块的综合分析[J].磁共振成像，

2023，14（04）：46-50+94.

[14]孙欣栋，鲍海华.磁共振高分辨率血管壁成像对

颈动脉体瘤合并颈动脉斑块的综合分析[J].磁共振成像，

2023，14（04）：46-50+94.

[15]Palanca A, Castelblanco E, Perpiñán H, Betriu

À, Soldevila B, Valdivielso JM, Bermúdez M, Duran X,

Fernández E, Puig-Domingo M, Groop PH, Alonso

N, Mauricio D. Prevalence and progression of subclinical

atherosclerosis in patients with chronic kidney disease and

diabetes. Atherosclerosis. 2018 Sep;276:50-57. doi: 10.1016/

j.atherosclerosis.2018.07.018. Epub 2018 Jul 19. PMID:

30032025.

[16]Saba L, Anzidei M, Sanfilippo R, Montisci R,

Lucatelli P, Catalano C, Passariello R, Mallarini G. Imaging of

the carotid artery. Atherosclerosis. 2012 Feb;220(2):294-309.

doi: 10.1016/j.atherosclerosis.2011.08.048. Epub 2011 Sep

17. PMID: 21968317.

[17]Saba L, Sanfilippo R, Sannia S, Anzidei M, Montisci

R, Mallarini G, Suri JS. Association between carotid artery

plaque volume, composition, and ulceration: a retrospective

assessment with MDCT. AJR Am J Roentgenol. 2012

Jul;199(1):151-6. doi: 10.2214/AJR.11.6955. PMID:

22733906.

[18]Naghavi M, Libby P, Falk E, Casscells SW, Litovsky

S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P,

Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P,

Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ,

Siscovick DS, de Korte CL, Aikawa M, Juhani Airaksinen

KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis

ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March

K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr

R, Grundy SM, Mehran R, Colombo A, Boerwinkle E,

Ballantyne C, Insull W Jr, Schwartz RS, Vogel R, Serruys

PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland

P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK,

Willerson JT. From vulnerable plaque to vulnerable patient:

a call for new definitions and risk assessment strategies: Part I.

Circulation. 2003 Oct 7;108(14):1664-72. doi: 10.1161/01.

CIR.0000087480.94275.97. PMID: 14530185.

[19]Naghavi M, Libby P, Falk E, Casscells SW, Litovsky

S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P,

Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P,

Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ,

Siscovick DS, de Korte CL, Aikawa M, Airaksinen KE,

Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS,

Jackson C, Jang IK, Koenig W, Lodder RA, March K,

Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr

R, Grundy SM, Mehran R, Colombo A, Boerwinkle E,

Ballantyne C, Insull W Jr, Schwartz RS, Vogel R, Serruys

PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland

P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK,

Willerson JT. From vulnerable plaque to vulnerable patient: a

call for new definitions and risk assessment strategies: Part II.

Circulation. 2003 Oct 14;108(15):1772-8. doi: 10.1161/01.

CIR.0000087481.55887.C9. PMID: 14557340.

[20]Cires-Drouet RS, Mozafarian M, Ali A, Sikdar S,

Lal BK. Imaging of high-risk carotid plaques: ultrasound.

Semin Vasc Surg. 2017 Mar;30(1):44-53. doi: 10.1053/

j.semvascsurg.2017.04.010. Epub 2017 Apr 27. PMID:

28818258.

[21]Hobson RW 2nd, Lal BK, Chakhtoura E, Goldstein

J, Haser PB, Kubicka R, Cerveira J, Pappas PJ, Padberg

FT, Jamil Z. Carotid artery stenting: analysis of data for 105

patients at high risk. J Vasc Surg. 2003 Jun;37(6):1234-9.

doi: 10.1016/s0741-5214(02)75448-7. Erratum in: J Vasc

Surg. 2003 Sep;38(3):497. Chaktoura Ellie Y [corrected to

Chakhtoura Elie Y]. PMID: 12764270.

[22]Golemati S, Sassano A, Lever MJ, Bharath AA,

Dhanjil S, Nicolaides AN. Carotid artery wall motion

estimated from B-mode ultrasound using region tracking and

block matching. Ultrasound Med Biol. 2003 Mar;29(3):387-

99. doi: 10.1016/s0301-5629(02)00760-3. PMID: 12706190.

[23]Silvennoinen HM, Ikonen S, Soinne L, Railo

M, Valanne L. CT angiographic analysis of carotid artery

stenosis: comparison of manual assessment, semiautomatic

vessel analysis, and digital subtraction angiography. AJNR Am

J Neuroradiol. 2007 Jan;28(1):97-103. PMID: 17213433;

PMCID: PMC8134104.[24]Ababneh B, Rejjal L, Pokharel Y, Nambi V, Wang

X, Tung CH, Han RI, Taylor AA, Kougias P, Lumsden AB,

Lawrie G, Reardon M, Ballantyne CM, Morrisett JD, Brunner

G. Distribution of calcification in carotid endarterectomy

tissues: comparison of micro-computed tomography imaging

with histology. Vasc Med. 2014 Oct;19(5):343-50. doi:

10.1177/1358863X14549270. Epub 2014 Sep 5. PMID:

25193489.

[25]JM UK-I, Fox AJ, Aviv RI, et al: Characterization

of carotid plaque hemorrhage: a CT angiography and MR

intraplaque hemorrhage study. Stroke; a journal of cerebral

circulation 2010, 41(8):1623-1629.

[26]Saba L, Mallarin G. Window settings for the study of

calcified carotid plaques with multidetector CT angiography.

AJNR Am J Neuroradiol. 2009 Aug;30(7):1445-50. doi:

10.3174/ajnr.A1509. Epub 2009 Mar 19. PMID: 19299487;

PMCID: PMC7051539.

[27]Andreucci M, Solomon R, Tasanarong A: Side

effects of radiographic contrast media: pathogenesis, risk

factors, and prevention. Biomed Res Int 2014, 2014:741018.

[28]Nickoloff EL, Alderson PO. Radiation exposures to

patients from CT: reality, public perception, and policy. AJR

Am J Roentgenol. 2001 Aug;177(2):285-7. doi: 10.2214/

ajr.177.2.1770285. PMID: 11461846.

[29]Murray CSG, Nahar T, Kalashyan H, Becher H,

Nanda NC. Ultrasound assessment of carotid arteries: Current

concepts, methodologies, diagnostic criteria, and technological

advancements. Echocardiography. 2018 Dec;35(12):2079-

2091. doi: 10.1111/echo.14197. PMID: 30506607.

[30]Kwee RM, van Oostenbrugge RJ, Hofstra L,

Teule GJ, van Engelshoven JM, Mess WH, Kooi ME.

Identifying vulnerable carotid plaques by noninvasive

imaging. Neurology. 2008 Jun 10;70(24 Pt 2):2401-9. doi:

10.1212/01.wnl.0000314697.76580.cb. PMID: 18541873.

[31]Zavodni AE, Wasserman BA, McClelland RL,

Gomes AS, Folsom AR, Polak JF, Lima JA, Bluemke DA.

Carotid artery plaque morphology and composition in relation

to incident cardiovascular events: the Multi-Ethnic Study of

Atherosclerosis (MESA). Radiology. 2014 May;271(2):381-9.

doi: 10.1148/radiol.14131020. Epub 2014 Mar 4. PMID:

24592924; PMCID: PMC4263652.

[32]Gimnich OA, Zil-E-Ali A, Brunner G. Imaging

Approaches to the Diagnosis of Vascular Diseases. Curr

Atheroscler Rep. 2022 Feb;24(2):85-96. doi: 10.1007/

s11883-022-00988-x. Epub 2022 Jan 26. PMID: 35080717.

[33]Takai H, Uemura J, Yagita Y, Ogawa Y, Kinoshita

K, Hirai S, Ishihara M, Hara K, Toi H, Matsubara S,

Nishimura H, Uno M. Plaque Characteristics of Patients

with Symptomatic Mild Carotid Artery Stenosis. J Stroke

Cerebrovasc Dis. 2018 Jul;27(7):1930-1936. doi: 10.1016/j.j

strokecerebrovasdis.2018.02.032. Epub 2018 Mar 20. PMID:

29571763.

[34]姜美琪，赵锋，马国芳，等.DRGs在西北地区

某综合医院骨科绩效评价中的应用[J].新疆医科大学学

报，2021，44（08）：971-974+980.

[35]刘钰佳.DRGs支付方式下对县级公立医院成本

核算的思考[J].环渤海经济瞭望，2022，（03）：165-167.

DOI：10.16457/j.cnki.hbhjjlw.2022.03.046.


Refbacks

  • 当前没有refback。